To this end, tissue samples obtained by biopsy or during tumor resection are analyzed by immunohistochemistry for the most frequent IDH mutation (IDH1R132H), which may be complemented by DNA sequencing to detect other non-canonical mutations in IDH1 or IDH2. The gene discussed is IDH1; the disease is neoplasm.